2633-4941

Therapeutic Advances in Reproductive Health

SAGE Publications

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 10 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact10 DOIs
2

Add abstracts to 7 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact7 DOIs

DOIs for this ISSN

Showing the top 5 of 113 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Double or dual stimulation in poor ovarian responders: where… (10.1177/26334941211024172)
ORCID
30.10 15
2 Treatment modalities for poor ovarian responders (10.1177/26334941221147464)
Abstract ORCID
30.10 3
3 Emerging concepts in male contraception: a narrative review… (10.1177/26334941221138323)
ORCID
26.98 11
4 Reversible interventions for menstrual management in adolesc… (10.1177/26334941231158251)
ORCID
26.03 10
5 Neurokinin receptor antagonists as potential non-hormonal tr… (10.1177/26334941231177611)
ORCID
22.58 7
6 The role of artificial intelligence in transforming maternit… (10.1177/26334941241288587)
Abstract
21.13 6
7 Intralipid infusion therapy as an adjunct treatment in women… (10.1177/26334941231181258)
ORCID
17.47 4
8 Advances in contraception: vaginal contraceptive rings (10.1177/26334941231186733)
ORCID
17.47 4
9 Pregnancy and breastfeeding during COVID-19 pandemic (10.1177/2633494120962526)
Abstract
7.53 1
10 The future of final follicle maturation in IVF with a person… (10.1177/26334941261423431)
Abstract
7.53 1
11 Patient perspectives and experiences with… (10.1177/2633494119899942)
0.00 18
12 Surgical adhesions among women undergoing laparoscopic gynec… (10.1177/2633494120906010)
0.00 5
13 The insulin signaling pathway is dysregulated in cumulus cel… (10.1177/2633494120906866)
0.00 9
14 Ejaculatory abstinence in semen analysis: does it make any s… (10.1177/2633494120906882)
0.00 11
15 What is new in the landscape of insulin-sensitizing agents f… (10.1177/2633494120908709)
0.00 9
16 The stair-step approach in treatment of anovulatory PCOS pat… (10.1177/2633494120908818)
0.00 8
17 Reaching women with obesity to support weight loss before pr… (10.1177/2633494120909106)
0.00 0
18 Studies on the basic issues relevant to sperm cryopreservati… (10.1177/2633494120909375)
0.00 5
19 Attitudes and experiences of health care professionals when… (10.1177/2633494120911036)
0.00 12
20 Characteristics of polycystic ovary syndrome throughout life (10.1177/2633494120911038)
0.00 112
21 Controversies in the diagnosis of polycystic ovary syndrome (10.1177/2633494120913032)
0.00 34
22 The obligate need for accuracy in reporting preclinical stud… (10.1177/2633494120917350)
0.00 0
23 Laboratory and clinical management of leukocytospermia and h… (10.1177/2633494120922511)
0.00 24
24 Risk factors for women’s non-utilization of decentralized pr… (10.1177/2633494120928340)
0.00 8
25 Serum estradiol levels in infertile men with non-obstructive… (10.1177/2633494120928342)
0.00 9
26 Intimate partner violence among postpartum women at a teachi… (10.1177/2633494120928346)
0.00 6
27 Update on the management of poor ovarian response in IVF: th… (10.1177/2633494120941480)
0.00 58
28 Conception rates after fluoroscopy-guided fallopian tubal ca… (10.1177/2633494120954248)
0.00 4
29 Elagolix in the treatment of endometriosis: impact beyond pa… (10.1177/2633494120964517)
0.00 9
30 The clinical use of time-lapse in human-assisted reproductio… (10.1177/2633494120976921)
0.00 15
31 Factors associated with modern family planning use among wom… (10.1177/2633494120976961)
0.00 4
32 A review of maternal overweight and obesity and its impact o… (10.1177/2633494120986544)
0.00 66
33 Preimplantation genetic testing for aneuploidy in uterus tra… (10.1177/26334941211009848)
0.00 6
34 A rational diagnostic approach to the “phantom hCG” and othe… (10.1177/26334941211016412)
0.00 9
35 Subarachnoid haemorrhage in pregnancy after… (10.1177/26334941211023542)
ORCID
0.00 0
36 Mitochondrial enrichment in infertile patients: a review of… (10.1177/26334941211023544)
0.00 19
37 Type and dose of gonadotropins in poor ovarian responders: d… (10.1177/26334941211024203)
0.00 6
38 The role of midwives and obstetrical nurses in the promotion… (10.1177/26334941211031866)
0.00 42
39 Poor ovarian response and the possible role of natural and m… (10.1177/26334941211062026)
0.00 12
40 Evaluation of predictor factors of psychological distress in… (10.1177/26334941211068010)
0.00 4
41 Air quality in the clinical embryology laboratory: a mini-re… (10.1177/2633494121990684)
0.00 10
42 Human growth hormone use in poor ovarian response – caution… (10.1177/2633494121999420)
0.00 4
43 Controlled amnioreduction for twin-to-twin transfusion syndr… (10.1177/26334941221080727)
0.00 3
44 Mechanisms of action of currently available woman-controlled… (10.1177/26334941221107120)
0.00 6
45 Effects of sperm processing techniques on IVF pregnancy rate… (10.1177/26334941231188656)
0.00 3
46 Risk of ovarian hyperstimulation syndrome in women with mali… (10.1177/26334941231196545)
0.00 3
47 Ethnic disparities in the incidence of gynecologic malignanc… (10.1177/26334941231209496)
0.00 1
48 Refusal of the hospitalization: a distressed dilemma in obst… (10.1177/26334941231216531)
0.00 0
49 Barriers to fertility preservation access in transgender and… (10.1177/26334941231222120)
0.00 13
50 Comparison of efficacy between levonorgestrel intrauterine s… (10.1177/26334941241227401)
0.00 10